Further investigations demonstrated that IL-13 inhibits TNF-α production following allogeneic bone marrow transplantation while enhancing the secretion of IL-4 and IL-5, thereby supporting the notion that IL-13 plays a protective role in GVHD [97]. Here, IL5 is linked to graft versus host disease.